Overview

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate experimental medication BMS-986231 in patients with different levels of kidney function.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb